attachment
attachment

Answer

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Here is the complete, structured answer to both questions:

Clinical Case Analysis

Case Summary

A 70-year-old woman from a nursing home presents with:
  • 2 days of productive cough, fever (38.9°C/102.1°F), and worsening dyspnea
  • HR 104, BP 130/85, RR 28, SpO2 91% on 3L NC
  • Altered mental status (slow to answer)
  • Dry, warm skin; no JVD, no S3/S4, no lower extremity edema, no calf tenderness

1. Most Likely Diagnosis: Pulmonary Embolism (PE)

Why PE and not Pneumonia?

This is a classic PE "masquerader" - the productive cough and fever superficially suggest pneumonia, but several features point strongly toward PE:
FeatureThis PatientSignificance
Age >70YesMajor PE risk factor
Nursing home (immobility)YesImmobilization - major risk
Diabetes, hypertension, hypercholesterolemiaYesVascular risk factors
HR 104YesTachycardia (fails PERC rule)
RR 28YesTachypnea
SpO2 91% on 3L NCYesHypoxemia (fails PERC rule)
Altered mentationYesSuggests significant hemodynamic effect
No JVD, no S3/S4AbsentArgues against heart failure
No calf tenderness/edemaAbsentDoes not rule out PE (DVT absent in >70%)
Key discriminating point: Per Rosen's Emergency Medicine, fever in PE is typically low-grade; a temperature >101.5°F (38.6°C) usually suggests infection - however, this patient's temperature of 38.9°C (102.1°F) is only marginally above that threshold. The absence of JVD, S3/S4 (ruling out heart failure), dry/warm skin, and the constellation of immobility + tachycardia + hypoxia in an elderly nursing home patient makes PE the most likely unifying diagnosis.
PERC Rule: This patient fails PERC on multiple criteria (age >50, HR >100, SpO2 <95%), meaning PE cannot be ruled out clinically - objective testing is required.
Revised Geneva Score:
  • Age >65 = 1 point
  • HR 75-94 = 3 points (HR 104 would be >95 = 5 points)
  • Immobilization (nursing home) = 2 points
  • Total: ~8-9 points = Intermediate-to-high probability

2. Management

Step 1: Immediate Stabilization

  • Supplemental O2 (already on 3L NC; titrate to SpO2 >94%)
  • IV access, continuous cardiac monitoring, pulse oximetry
  • 12-lead ECG (look for right heart strain: S1Q3T3, T-wave inversions V1-V4, RBBB)

Step 2: Diagnostic Workup (run in parallel)

  • CT Pulmonary Angiography (CTPA) - gold standard, test of choice in this hemodynamically stable patient
  • D-dimer - high sensitivity (95-98%), though in this intermediate-high pretest probability patient, a negative result may still not rule out PE; CTPA is preferred
  • Troponin + BNP/NT-proBNP - for risk stratification (RV dysfunction markers)
  • CBC, BMP, coagulation studies - baseline before anticoagulation
  • Chest X-ray - often normal or shows non-specific changes (Westermark sign, Hampton's hump rare)
  • Bilateral lower extremity ultrasound - look for DVT source
  • ABG if needed to quantify hypoxemia

Step 3: Anticoagulation (initiate IMMEDIATELY - do not wait for confirmatory results)

Per Goldman-Cecil Medicine: "Anticoagulation is the cornerstone of treatment for VTE and should be initiated immediately in patients with suspected pulmonary embolism or DVT even while awaiting the results of confirmatory tests."
First-line options:
  • Low-molecular-weight heparin (LMWH) - e.g., enoxaparin 1 mg/kg SC q12h - preferred in most patients
  • Direct oral anticoagulants (DOACs) - rivaroxaban or apixaban can be used as monotherapy from the start (rivaroxaban: 15 mg BID x 21 days, then 20 mg daily; apixaban: 10 mg BID x 7 days, then 5 mg BID)
  • Unfractionated heparin (UFH) IV - preferred if thrombolysis or procedure is being considered (short half-life, reversible with protamine)
Avoid DOACs if: severe renal impairment, significant drug interactions, or instability requiring thrombolysis.

Step 4: Risk Stratification Guides Further Treatment

Risk CategoryDefinitionTreatment
High-risk (massive PE)Hypotension (SBP <90) or hemodynamic collapseAnticoagulation + systemic thrombolysis (alteplase 100 mg IV over 2 hrs) or surgical thrombectomy
Intermediate-riskNormotensive + RV dysfunction on echo or elevated troponinAnticoagulation; consider CDT or thrombolysis if deteriorates
Low-riskNo hemodynamic compromise, no RV dysfunctionAnticoagulate; consider early discharge/outpatient treatment
This patient is currently hemodynamically stable (BP 130/85, no shock) - placing her in at least the intermediate risk category given her tachycardia, hypoxia, and altered mentation. Inpatient admission is appropriate.

Step 5: Thrombolysis - When?

Reserved for high-risk PE (hemodynamic compromise, SBP <90) without contraindications. Not indicated here unless she deteriorates. Per Rosen's: alteplase 100 mg IV over 2 hours is the standard regimen.

Step 6: Duration of Anticoagulation

  • Provoked PE (identifiable risk factor like immobility): minimum 3 months
  • Extended therapy beyond 3 months depends on whether the risk factor is permanent and the bleeding risk

Step 7: Supportive Care

  • Treat fever with acetaminophen (reduces O2 consumption)
  • Aspiration precautions given altered mentation
  • Consider IVC filter only if absolute contraindication to anticoagulation

Sources: - Rosen's Emergency Medicine, pp. 1202-1211 | Goldman-Cecil Medicine, pp. 805-806
This is a shared conversation. Sign in to Orris to start your own chat.